Almac’s Graham Nicholls to speak at CTS Europe conference
Will provide an overview of adaptive trial designs and comment on regulatory and logistical perspectives
Graham Nicholls, director of biostatistics for Almac’s Clinical Technologies business unit, will be speaking at the Clinical Trial Supply Europe conference (CTS Europe) held in Barcelona, Spain, on 22-23 February 2011.
The conference will be attended by two of Almac’s business units directly involved with providing an integrated clinical supply chain solution involving IXRS technology, planning, forecasting, packaging, labelling, analytical testing, inventory management, and global distribution of supplies for clinical trials.
Nicholls plans to speak on the topic of the challenges of conducting adaptive trials. A notable expert on this subject, he will provide an overview of adaptive trial designs and comment on some of the current regulatory and logistical perspectives of implementing such trials on a global basis.
Additionally, he will address some of the particular challenges that adaptive trial designs have on clinical supplies planning, as well as on manufacturing, packaging, and IXRS technology considerations.
‘Graham’s knowledge of dynamic randomisation strategies has helped Almac solidify its reputation as an industry leader in adaptive and other complex trial designs,’ said Jim Murphy, president of Almac’s Clinical Technologies business unit. ‘His knowledge complements Almac’s logistical expertise in managing clinical supply chains on a global basis, providing our clients with a full-service drug supply management solution for adaptive trials that is unmatched in our industry.
‘As we are seeing an increasing number of adaptive trials, it is important to share Graham’s extensive knowledge at conferences, such as CTS Europe, to help sponsors plan and execute on complex study designs.’
Almac will be showcasing its integrated technology and clinical supply chain solution at booth 19 at the CTS Europe show.
